![Li Ju Yeh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Li Ju Yeh
Director/Miembro de la Junta en DELTA ASIA INTERNATIONAL CORPORATION .
Cargos activos de Li Ju Yeh
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DELTA ASIA INTERNATIONAL CORPORATION | Director/Miembro de la Junta | 12/11/2019 | - |
Independent Dir/Board Member | 12/11/2019 | - | |
TRICORNTECH TAIWAN CORPORATION | Director/Miembro de la Junta | - | - |
Independent Dir/Board Member | - | - |
Historial de carrera de Li Ju Yeh
Antiguos cargos conocidos de Li Ju Yeh.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TWI BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 18/06/2013 | 01/09/2019 |
Director Financiero/CFO | 18/06/2013 | 01/09/2019 | |
Public Communications Contact | - | 01/09/2019 | |
Ventas & Marketing | 18/06/2013 | - | |
TWI PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/12/2011 | - |
Director Financiero/CFO | 01/12/2011 | - | |
Public Communications Contact | 01/12/2011 | - |
Formación de Li Ju Yeh.
National Sun Yat-Sen University | Graduate Degree |
Estadísticas
Internacional
Taiwán | 6 |
Operativa
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 2 |
Public Communications Contact | 2 |
Sectorial
Health Technology | 4 |
Consumer Services | 2 |
Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
TWI BIOTECHNOLOGY, INC. | Health Technology |
DELTA ASIA INTERNATIONAL CORPORATION | Health Technology |
TRICORNTECH TAIWAN CORPORATION | Electronic Technology |
Empresas privadas | 1 |
---|---|
TWi Pharmaceuticals, Inc.
![]() TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
- Bolsa de valores
- Insiders
- Li Ju Yeh
- Experiencia